In8Bio INAB Income Statement (2020-2026)

NASDAQ INAB
$1.21 +0.01 (+0.83%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
0.45M0.33M0.63M0.63M0.82M0.82M0.83M1.02M1.07M1.00M1.44M1.55M1.56M1.78M2.71M4.08M4.59M4.37M19.47M
Operating items
Research & Development (Quarter)
1.35M2.69M2.38M3.50M4.25M3.92M4.38M4.13M3.79M-3.82M2.52M5.16M3.31M10.38M2.97M1.24M1.15M6.56M2.61M2.49M
Selling, General & Administrative (Quarter)
2.04M3.16M3.76M3.67M3.14M3.88M3.47M3.58M3.38M3.08M3.74M3.53M2.73M2.63M2.69M2.71M1.86M2.38M2.65M2.44M
Restructuring Costs (Quarter)
1.07M
Other Operating Expenses (Quarter)
8.34M2.38M-6.79M1.25M0.95M-3.91M
Operating Expenses (Quarter)
3.39M5.85M6.14M7.18M7.40M7.80M7.86M7.71M7.17M7.60M8.64M8.69M7.11M6.22M5.66M5.20M3.97M5.03M5.27M
Operating Income (Quarter)
-3.39M-5.85M-6.14M-7.18M-7.40M-7.80M-7.53M-7.71M-7.17M-7.60M-8.56M-8.63M-7.09M-6.16M-5.55M-5.09M-3.85M-4.94M-5.09M
EBIT (Quarter)
-3.39M-5.85M-6.14M-7.18M-7.40M-7.80M-7.53M-7.71M-7.17M-7.60M-8.56M-8.63M-7.09M-6.16M-5.55M-5.09M-3.85M-4.94M-5.09M
Non-operating items
Interest & Investment Income (Quarter)
0.08M0.06M0.02M0.06M0.11M0.11M0.11M0.09M0.18M
Net income details
EBT (Quarter)
-5.76M-6.83M-8.32M-7.64M-13.47M-8.66M-8.97M-9.51M-12.10M-27.24M-9.90M-14.32M-8.38M-31.29M-9.82M-5.67M-4.42M-4.85M-5.11M
Profit After Tax (Quarter)
-3.39M-5.85M-6.14M-7.18M-7.40M-7.80M-7.53M-7.71M-7.17M-7.60M-8.56M-8.63M-7.09M-6.16M-5.55M-5.09M-3.85M-4.94M-5.09M
Income from Continuing Operations (Quarter)
-5.76M-6.83M-8.32M-7.64M-13.47M-8.66M-8.97M-9.51M-12.10M-27.24M-9.90M-14.32M-8.38M-31.29M-9.82M-5.67M-4.42M-4.85M-5.11M
Consolidated Net Income (Quarter)
-5.76M-6.83M-8.32M-7.64M-13.47M-8.66M-8.97M-9.51M-12.10M-27.24M-9.90M-14.32M-8.38M-31.29M-9.82M-5.67M-4.42M-4.85M-5.11M
Income towards Parent Company (Quarter)
-5.76M-6.83M-8.32M-7.64M-13.47M-8.66M-8.97M-9.51M-12.10M-27.24M-9.90M-14.32M-8.38M-31.29M-9.82M-5.67M-4.42M-4.85M-5.11M
Net Income towards Common Stockholders (Quarter)
-3.39M-5.85M-6.14M-7.18M-7.40M-8.66M-8.97M-9.51M-12.10M-27.24M-9.90M-14.32M-8.38M-31.29M-9.82M-5.67M-4.42M-4.85M-5.11M
Additional items
EPS (Basic) (Quarter)
-7.61-17.60-9.81-11.44-10.25-12.39-10.89-10.02-11.51-27.37-6.86-9.52-5.32-17.53-3.53-1.38-0.97-1.11-0.26
EPS (Diluted) (Quarter)
-7.61-17.60-9.81-11.44-10.25-12.39-10.89-10.02-11.51-27.37-6.86-9.52-5.32-17.53-3.53-1.38-0.97-1.11-0.26
Shares Outstanding (Quarter)
0.45M0.33M0.63M0.63M0.72M0.70M0.82M0.95M1.05M1.00M1.44M1.50M1.58M1.78M2.78M4.12M4.54M4.37M19.47M
Shares Outstanding (Diluted) (Quarter)
0.45M0.33M0.63M0.63M0.72M0.70M0.82M0.95M1.05M1.00M1.44M1.50M1.58M1.78M2.78M4.12M4.54M4.37M19.47M
EBITDA (Quarter)
-3.39M-5.85M-6.14M-7.18M-7.40M-7.80M-7.53M-7.71M-7.17M-7.60M-8.56M-8.63M-7.09M-6.16M-5.55M-5.09M-3.85M-4.94M-5.09M
Interest Expenses (Quarter)
2.37M0.98M2.18M0.46M6.07M0.86M1.45M1.79M4.93M19.64M1.42M5.75M1.32M25.20M4.38M0.68M0.68M0.20M